Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/23/2000 | WO2000015793A2 Human gpcr proteins |
03/23/2000 | WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization |
03/23/2000 | WO2000015791A1 Ecdysone receptors and methods for their use |
03/23/2000 | WO2000015790A2 Leptin induced genes |
03/23/2000 | WO2000015789A1 Recombinant bioadhesive protein analogs comprising hydroxyproline |
03/23/2000 | WO2000015788A2 Dna sequence encoding oncofetal ferritin protein |
03/23/2000 | WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1 |
03/23/2000 | WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |
03/23/2000 | WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
03/23/2000 | WO2000015783A2 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE |
03/23/2000 | WO2000015780A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer |
03/23/2000 | WO2000015779A2 Molecular cloning using rolling circle amplification |
03/23/2000 | WO2000015778A1 Monolithic matrix for separating nucleic acids by reverse-phase ion-pair high performance liquid chromatography |
03/23/2000 | WO2000015777A1 Gene and protein libraries and methods relating thereto |
03/23/2000 | WO2000015776A1 Product and method for separation of a sample containing multiple sources of genetic material using a solid medium |
03/23/2000 | WO2000015775A1 Rnase p polypeptides |
03/23/2000 | WO2000015773A2 Inhibition of oncogene transcription by synthetic polyamides |
03/23/2000 | WO2000015772A2 Recombinant protein production in urine |
03/23/2000 | WO2000015771A1 Recombinant vanadium haloperoxidases and their uses |
03/23/2000 | WO2000015770A2 Human serine/threonine protein kinases |
03/23/2000 | WO2000015769A1 Topa |
03/23/2000 | WO2000015760A1 Streptococcal c beta protein compositions |
03/23/2000 | WO2000015759A1 Interleukin 17-like receptor protein |
03/23/2000 | WO2000015758A2 Plant resistance to insect pests mediated by viral proteins |
03/23/2000 | WO2000015666A2 Compositions and methods for the treatment of tumors |
03/23/2000 | WO2000015665A2 A method of producing a functional immunoglobulin superfamily protein |
03/23/2000 | WO2000015662A1 Regulatory sequences for root specific or root abundant gene expression in plants |
03/23/2000 | WO2000015661A1 Modified e. coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
03/23/2000 | WO2000015659A2 Stomach polypeptide zsig28 |
03/23/2000 | WO2000015651A1 Regulation of immune responses by attractin |
03/23/2000 | WO2000015650A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
03/23/2000 | WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
03/23/2000 | WO2000015648A1 Adenoviral vector encoding pro-apoptotic bax gene and uses thereof |
03/23/2000 | WO2000015641A1 Compounds alkylating specific base sequence of dna and method for synthesizing the same |
03/23/2000 | WO2000015265A1 Compositions and methods of use of uptake mechanisms for diagnostic and therapeutic applications of oligonucleotides targeting bacteria |
03/23/2000 | WO2000015263A1 Expandible microparticle intracellular delivery system |
03/23/2000 | WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
03/23/2000 | WO2000015247A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
03/23/2000 | WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
03/23/2000 | WO2000015243A1 A method of treatment and agents useful for same |
03/23/2000 | WO2000015242A1 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
03/23/2000 | WO2000015209A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
03/23/2000 | WO2000008160A3 A plant disease resistance signalling gene: materials and methods relating thereto |
03/23/2000 | WO2000008137A3 Transgenic animals having a modified glycoprotein v gene |
03/23/2000 | WO2000006747A3 Enzymes for biopolymer production |
03/23/2000 | WO2000004153A3 Repression of cell transformation with human pea3 |
03/23/2000 | WO2000003244A9 Immortalized human keratinocyte cell line |
03/23/2000 | WO2000002520A3 T-lymphocyte exchange |
03/23/2000 | WO2000000646A9 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
03/23/2000 | WO2000000611A3 14273 receptor, a g-protein coupled receptor |
03/23/2000 | WO2000000599A3 Composition for the induction of apoptosis in target cells |
03/23/2000 | WO2000000597A3 Non-symbiotic plant hemoglobins to maintain cell energy status |
03/23/2000 | WO1999067401A3 Non-food crop plant bioreactor |
03/23/2000 | WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
03/23/2000 | WO1999067269A9 Nucleic acid molecule encoding an ankyrin repeat tvl-1 protein and methods of use thereof |
03/23/2000 | WO1999067268A9 Diacylglycerol o-acyltransferase |
03/23/2000 | WO1999066024A9 Methods of monitoring disease states and therapies using gene expression profiles |
03/23/2000 | WO1999064569A9 Methods and compositions for generating recombinant adeno-associated virus vectors |
03/23/2000 | WO1999062847A3 Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components |
03/23/2000 | WO1999061619A3 Cell cycle genes, proteins and uses thereof |
03/23/2000 | WO1999061607A3 Antisense oligonucleotides for treating proliferating cells |
03/23/2000 | WO1999060842A3 Plant retroelements and methods related thereto |
03/23/2000 | WO1999060115A3 Proteins and genes useful as tumor markers |
03/23/2000 | WO1999060107A3 Nicotianamine synthase genes, isolation and use thereof |
03/23/2000 | WO1999058650A9 Lytic enzymes useful for treating fungal infections |
03/23/2000 | WO1999055876A3 Polypeptide with immunogenic properties and with a protein with modified biological functions |
03/23/2000 | WO1999054473A3 Bacterial yjeq polypeptide family |
03/23/2000 | WO1999053075A3 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants |
03/23/2000 | WO1999053069A3 Cell cycle regulatory proteins cdc2 and pitslre from plants |
03/23/2000 | WO1999053061A3 Tumor associated nucleic acids and uses therefor |
03/23/2000 | WO1999047684A3 Dehydrogenases with improved nad-dependence, the production thereof, and their use |
03/23/2000 | WO1999042588A3 Group b streptococcus antigens |
03/23/2000 | WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
03/23/2000 | DE19846979A1 New human and murine G-coupled receptor EDG (endothelial differentiation gene) 6, useful for modulating inflammatory and immune reactions and for treatment of allergy or tumors |
03/23/2000 | DE19842527A1 Formation of a triple helix forming oligomer comprises searching for a cytosine and/or adenine-rich region of a double-stranded DNA |
03/23/2000 | DE19841299A1 Novel gene for a variant Gbeta3-subunit of human G-protein useful for determining risk of G-protein dysfunction associated disease |
03/23/2000 | DE19840044A1 Oligonukleotide, Verfahren und Kit zur Detektion von Listeria monocytogenes durch Nukleinsäureamplifikation und/oder -hybridisierung Oligonucleotides, procedures and kit for the detection of Listeria monocytogenes by nucleic acid amplification and / or hybridization |
03/23/2000 | DE19836559A1 Gefäß zur Entnahme von Blut Vessel for collecting blood |
03/23/2000 | DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection |
03/23/2000 | CA2706859A1 Mammalian transforming growth factor beta - 9 |
03/23/2000 | CA2346262A1 Methods for treatment of degenerative retinal diseases |
03/23/2000 | CA2344654A1 Regulation of her2/neu oncogene expression by synthetic polyamines |
03/23/2000 | CA2344441A1 Expandible microparticle intracellular delivery system |
03/23/2000 | CA2343898A1 Maize sina orthologue-1 and uses thereof |
03/23/2000 | CA2343838A1 Atp synthase subunit homolog |
03/23/2000 | CA2343654A1 Method for down-regulating osteoprotegerin ligand activity |
03/23/2000 | CA2343578A1 Human serine/threonine protein kinases |
03/23/2000 | CA2343577A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/23/2000 | CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | CA2343354A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer |
03/23/2000 | CA2343352A1 A method of treatment and agents useful for same |
03/23/2000 | CA2343315A1 Process for making polycarboxylic acids |
03/23/2000 | CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
03/23/2000 | CA2343313A1 A method of producing a functional immunoglobulin superfamily protein |
03/23/2000 | CA2343220A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
03/23/2000 | CA2343107A1 Method and kit for detecting intrachromosome imbalance in inter phase nuclei and their applications |
03/23/2000 | CA2343104A1 Recombinant protein production in urine |
03/23/2000 | CA2343076A1 Geometrical and hierarchical classification based on gene expression |
03/23/2000 | CA2343072A1 Method of isolation primer extension products with modular oligonucleotides |